The current challenges and costs of GLP1 therapy highlight the urgent need for rigorous research on how staged or combination nutritional programs, including multiple components and possibly FIM therapies, might improve outcomes, mitigate weight regain or cycling, and promote health equity
It's about something else too, about why we do science in the first place, about why people and governments come together to give money to scientists, and about what kind of questions scientists should ask about what kind of knowledge is most useful and how science can do the most good for the world
Earlier this month, Medicare announced a bridge program to begin coverage of GLP-1 weight-loss drugs from July 1 through Dec
Kausel says, noting that some of the more serious potential side effects of Vyvanse include heart palpitations, arrhythmias (irregular heart rhythm), headaches, high blood pressure, insomnia, and psychosis